NOXXON Pharma is a clinical-stage biopharmaceutical company whose core focus is on improving cancer treatment by targeting the tumor microenvironment. NOXXON’s goal is to significantly enhance the effectiveness of cancer treatments including immuno-oncology approaches (such as immune checkpoint inhibitors) and current standards of care (such as chemotherapy and radiotherapy).
NOXXON's Spiegelmer® platform has generated a proprietary pipeline of clinical-stage assets including its lead cancer candidate NOX-A12, which is the subject of a clinical immuno-oncology collaboration agreement with Merck & Co. / MSD (NYSE: MRK) to study NOX-A12 combined with KEYTRUDA® (pembrolizumab) in pancreatic and colorectal cancer. NOXXON’s pipeline also contains NOX-E36, which targets other tumor microenvironment targets implicated in cancer spread and immune privilege of tumors.
Total raised: $66.339998M
Founded date: 1998
Investors 4
| Date | Name | Website |
| - | bmp Ventur... | bmp.com |
| - | Sofinnova ... | sofinnovap... |
| 03.08.2021 | Andera Par... | anderapart... |
| - | TVM Capita... | tvm-lifesc... |
Funding Rounds 6
| Date | Series | Amount | Investors | Deal News |
| 29.12.2021 | - | $19.183699... | - | marketscre... |
| 30.04.2021 | - | $1.449627M | - | marketscre... |
| 06.08.2019 | - | $1.1187M | - | biospace.c... |
| 09.05.2017 | - | $1.088626M | - | tvm-lifesc... |
| 12.10.2010 | Series D | $2.775599M | - | finsmes.co... |
| 27.05.2010 | - | $40.723747... | - | finsmes.co... |
Mentions in press and media 37
| Date | Title | Description | Category | Author | Source |
| 31.01.2022 | NOXXON ANN... | Berlin, Germany - NOXXON Pharm... | - | - | marketscre... |
| 29.12.2021 | NOXXON Pha... | NOXXON SECURES €17 MILLION EXP... | - | - | marketscre... |
| 15.12.2021 | NOXXON Pha... | NOXXON TO PARTICIPATE IN BANKI... | - | - | marketscre... |
| 15.12.2021 | NOXXON Pha... | NOXXON ANNOUNCES RESULTS OF TH... | - | - | marketscre... |
| 22.11.2021 | NOXXON: Ne... | NOXXON: NEW PHASE 1/2 DATA ON ... | - | - | marketscre... |
| 15.11.2021 | NOXXON Pha... | NOXXON ANNOUNCES CONVOCATION O... | - | - | marketscre... |
| 09.11.2021 | NOXXON to ... | NOXXON TO PRESENT AT THE THIR... | - | - | marketscre... |
| 03.11.2021 | NOXXON pro... | NOXXON PROVIDES UPDATE ON TIMI... | - | - | marketscre... |
| 27.10.2021 | Experience... | EXPERIENCED FINANCIAL EXECUTIV... | - | - | marketscre... |
| 19.10.2021 | NOXXON Pha... | NOXXON ANNOUNCES PLANNED EXPAN... | - | - | marketscre... |
Show more